Literature DB >> 17493584

Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos.

Paul A Morcos1.   

Abstract

This work represents the first guide for using steric-block antisense oligos as tools for effective and targeted modification of RNA splicing. Comparison of several steric-block oligo types shows the properties of Morpholinos provide significant advantages over other potential splice-blocking oligos. The procedures and complications of designing effective splice-blocking Morpholino oligos are described. The design process requires complete pre-mRNA sequence for defining suitable targets, which usually generate specific predictable messengers. To validate the targeting procedure, the level and nature of transcript alteration is characterized by RT-PCR analysis of splice modification in a beta-globin splice model system. An oligo-walking study reveals that while U1 and U2 small nuclear RiboNucleoProtein (snRNP) binding sites are the most effective targets for blocking splicing, inclusion of these sites is not required to achieve effective splice modifications. The most effective targeting strategy employs simultaneously blocking snRNP binding sites and splice-junctions. The work presented here continues to be the basis for most of the successful Morpholino oligos designed for the worldwide research community to block RNA splicing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493584     DOI: 10.1016/j.bbrc.2007.04.172

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  66 in total

1.  Gene knockdown by morpholino-modified oligonucleotides in the zebrafish (Danio rerio) model: applications for developmental toxicology.

Authors:  Alicia R Timme-Laragy; Sibel I Karchner; Mark E Hahn
Journal:  Methods Mol Biol       Date:  2012

2.  Morpholino injection in Xenopus.

Authors:  Panna Tandon; Chris Showell; Kathleen Christine; Frank L Conlon
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Reverse genetics in eukaryotes.

Authors:  Serge Hardy; Vincent Legagneux; Yann Audic; Luc Paillard
Journal:  Biol Cell       Date:  2010-10       Impact factor: 4.458

4.  Deficiency of a transmembrane prolyl 4-hydroxylase in the zebrafish leads to basement membrane defects and compromised kidney function.

Authors:  Jaana Hyvärinen; Mataleena Parikka; Raija Sormunen; Mika Rämet; Karl Tryggvason; Kari I Kivirikko; Johanna Myllyharju; Peppi Koivunen
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

5.  The calmodulin-stimulated adenylate cyclase ADCY8 sets the sensitivity of zebrafish retinal axons to midline repellents and is required for normal midline crossing.

Authors:  Hong Xu; Sarah G Leinwand; Alison L Dell; Emma Fried-Cassorla; Jonathan A Raper
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

6.  Retinal homeobox 1 is required for retinal neurogenesis and photoreceptor differentiation in embryonic zebrafish.

Authors:  Steve M Nelson; Leon Park; Deborah L Stenkamp
Journal:  Dev Biol       Date:  2009-01-10       Impact factor: 3.582

7.  Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum.

Authors:  Liutao Du; Refik Kayali; Carmen Bertoni; Francesca Fike; Hailiang Hu; Patrick L Iversen; Richard A Gatti
Journal:  Hum Mol Genet       Date:  2011-05-16       Impact factor: 6.150

8.  Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis.

Authors:  Hani Bagheri; Chansonette Badduke; Ying Qiao; Rita Colnaghi; Iga Abramowicz; Diana Alcantara; Christopher Dunham; Jiadi Wen; Robert S Wildin; Malgorzata Jm Nowaczyk; Jennifer Eichmeyer; Anna Lehman; Bruno Maranda; Sally Martell; Xianghong Shan; Suzanne Me Lewis; Mark O'Driscoll; Cheryl Y Gregory-Evans; Evica Rajcan-Separovic
Journal:  JCI Insight       Date:  2016-03-17

9.  GIPC proteins negatively modulate Plexind1 signaling during vascular development.

Authors:  Jorge Carretero-Ortega; Zinal Chhangawala; Shane Hunt; Carlos Narvaez; Javier Menéndez-González; Carl M Gay; Tomasz Zygmunt; Xiaochun Li; Jesús Torres-Vázquez
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

10.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.